Literature DB >> 15947040

Image-guided tumor ablation: standardization of terminology and reporting criteria.

S Nahum Goldberg1, Clement J Grassi, John F Cardella, J William Charboneau, Gerald D Dodd, Damian E Dupuy, Debra Gervais, Alice R Gillams, Robert A Kane, Fred T Lee, Tito Livraghi, John McGahan, David A Phillips, Hyunchul Rhim, Stuart G Silverman.   

Abstract

The field of interventional oncology with use of image-guided tumor ablation requires standardization of terminology and reporting criteria to facilitate effective communication of ideas and appropriate comparison between treatments that use different technologies, such as chemical (ethanol or acetic acid) ablation, and thermal therapies, such as radiofrequency (RF), laser, microwave, ultrasound, and cryoablation. This document provides a framework that will hopefully facilitate the clearest communication between investigators and will provide the greatest flexibility in comparison between the many new, exciting, and emerging technologies. An appropriate vehicle for reporting the various aspects of image-guided ablation therapy, including classification of therapies and procedure terms, appropriate descriptors of imaging guidance, and terminology to define imaging and pathologic findings, are outlined. Methods for standardizing the reporting of follow-up findings and complications and other important aspects that require attention when reporting clinical results are addressed. It is the group's intention that adherence to the recommendations will facilitate achievement of the group's main objective: improved precision and communication in this field that lead to more accurate comparison of technologies and results and, ultimately, to improved patient outcomes. The intent of this standardization of terminology is to provide an appropriate vehicle for reporting the various aspects of image-guided ablation therapy.

Entities:  

Mesh:

Year:  2005        PMID: 15947040     DOI: 10.1097/01.RVI.0000170858.46668.65

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  75 in total

1.  [Radiofrequency ablation as a palliative therapy option in ENT tumors: in vivo and in vitro testing].

Authors:  S Bucher; J Hornung; V Bonkowsky; H Iro; J Zenk
Journal:  HNO       Date:  2010-04       Impact factor: 1.284

Review 2.  Complications of intraoperative radiofrequency ablation of liver metastases.

Authors:  Tsiriniaina Razafindratsira; Milène Isambert; Serge Evrard
Journal:  HPB (Oxford)       Date:  2010-12-07       Impact factor: 3.647

3.  Treatment efficacy and safety of ultrasound-guided percutaneous bipolar radiofrequency ablation for benign thyroid nodules.

Authors:  Xiao-Long Li; Hui-Xiong Xu; Feng Lu; Wen-Wen Yue; Li-Ping Sun; Xiao-Wan Bo; Le-Hang Guo; Jun-Mei Xu; Bo-Ji Liu; Dan-Dan Li; Shen Qu
Journal:  Br J Radiol       Date:  2016-01-22       Impact factor: 3.039

4.  Combination treatment with comprehensive cryoablation and immunotherapy in metastatic hepatocellular cancer.

Authors:  Li-Zhi Niu; Jia-Liang Li; Jian-Ying Zeng; Feng Mu; Meng-Tian Liao; Fei Yao; Li Li; Chun-Yan Liu; Ji-Bing Chen; Jian-Sheng Zuo; Ke-Cheng Xu
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

5.  Radiofrequency ablation for hepatocellular carcinoma: use of low vs maximal radiofrequency power.

Authors:  T C Macatula; C-C Lin; C-J Lin; W-T Chen; S-M Lin
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

6.  Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.

Authors:  Raja Shaikh; Ahmad I Alomari; Cindy L Kerr; Patricia Miller; Samantha A Spencer
Journal:  Pediatr Radiol       Date:  2016-02-22

7.  Complications of radiofrequency ablation of neoplasms.

Authors:  Albert A Nemcek
Journal:  Semin Intervent Radiol       Date:  2006-06       Impact factor: 1.513

8.  Radical treatment of stage IV pancreatic cancer by the combination of cryosurgery and iodine-125 seed implantation.

Authors:  Ji-Bing Chen; Jia-Liang Li; Li-Hua He; Wei-Qun Liu; Fei Yao; Jian-Ying Zeng; Yi Zhang; Ke-Qiang Xu; Li-Zhi Niu; Jian-Sheng Zuo; Ke-Cheng Xu
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Incidence and treatment of local site recurrences following RFA of colorectal liver metastases.

Authors:  Karin Nielsen; Aukje A J M van Tilborg; Martijn R Meijerink; Matessa O Macintosh; Babs M Zonderhuis; Elly S M de Lange; Emile F I Comans; Sybren Meijer; M Petrousjka van den Tol
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

10.  Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.

Authors:  Suk Kyeong Ji; Yun Ku Cho; Yong Sik Ahn; Mi Young Kim; Yoon Ok Park; Jae Kyun Kim; Wan Tae Kim
Journal:  Korean J Radiol       Date:  2008 Nov-Dec       Impact factor: 3.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.